New Brunswick, NJ, United States of America

Nipa Vatsaraj



 

Average Co-Inventor Count = 8.0

ph-index = 5

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Nipa Vatsaraj: Pioneering Innovations in Pharmaceutical Formulations

Introduction

Nipa Vatsaraj, based in New Brunswick, NJ, is a noteworthy inventor recognized for her significant contributions in the field of pharmaceuticals. With a total of five patents to her name, Nipa has made impactful strides in developing innovative medicinal formulations.

Latest Patents

Among her latest patents, Nipa Vatsaraj has developed pharmaceutical formulations containing an SGLT2 inhibitor, specifically designed for immediate release. These formulations are available in the form of capsules or tablets for oral use and include the medicament dapagliflozin or its propylene glycol hydrate, accompanied by a pharmaceutical acceptable carrier. The focus on immediate release offers promising advantages in therapeutic applications and patient compliance.

Career Highlights

Nipa has had a remarkable career, working with prominent companies like Bristol-Myers Squibb Company and AstraZeneca AB. Her expertise and innovative mindset have been vital in advancing pharmaceutical technologies, optimizing drug delivery systems, and improving patient outcomes.

Collaborations

Throughout her career, Nipa has collaborated with esteemed professionals in the industry, including Dilbir S. Bindra and Mandar V. Dali. These collaborations have contributed to her success and the further development of her groundbreaking inventions.

Conclusion

In summary, Nipa Vatsaraj exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through multiple patents not only showcase her ingenuity but also pave the way for future advancements in drug formulation and delivery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…